Updated Jul 16, 2026
Infante (Reynolds) Marie C has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Infante (Reynolds) Marie C is the name used in SEC filings to designate a director of OrthoPediatrics Corp as of June 10, 2026. The SEC context confirms a board role at OrthoPediatrics, but does not provide additional biographical details such as prior positions, background, or tenure beyond the director designation.
| Role | Director |
|---|---|
| Notability | 42/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-10 | KIDS | ORTHOPEDIATRICS CORP | A — Grant or award | 11.4K | $0.00 |
Infante (Reynolds) Marie C is the name used in SEC filings to designate a director of OrthoPediatrics Corp as of June 10, 2026. The SEC context confirms a board role at OrthoPediatrics, but does not provide additional biographical details such as prior positions, background, or tenure beyond the director designation.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Infante (Reynolds) Marie C profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.